BlackRock, Inc. 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
BlackRock Inc. BLK |
21,881,203 8.500% |
-2,360,234 (-9.74%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
BlackRock Inc. BLK |
24,241,437 9.400% |
296,506 (+1.24%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
BlackRock Inc. BLK |
23,944,931 9.400% |
-323,964 (-1.33%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
BlackRock Inc. BLK |
24,268,895 9.300% |
3,152,074 (+14.93%) |
Filing |